1387. New and Emerging Therapies
Session: Symposium: The Challenge of Respiratory Viruses in Transplantation
Sunday, October 23, 2011: 8:30 AM
Room: 205ABC


Frederick Hayden, MD, FIDSA, University of Virginia Health Sciences Center, Charlottesville, VA; World Health Organization, Geneva 27, Switzerland

Frederick G. Hayden, MD, FACP is Stuart S. Richardson Professor of Clinical Virology and Professor of Medicine at the University of Virginia School of Medicine in Charlottesville, Virginia, USA. During 2006-2008 he served as a medical officer in the Global Influenza Programme at the World Health Organization, Geneva, Switzerland and since September 2008 has been serving as influenza research coordinator at the Wellcome Trust, London. Dr Hayden received his medical degree from Stanford University School of Medicine in 1973 and completed his clinical training in internal medicine and infectious diseases at Strong Memorial Hospital, University of Rochester, New York. He joined the faculty of the University of Virginia School of Medicine in 1978 and became Richardson Professor in 1990. His principle research interests have been on respiratory viral infections with a particular focus on the development and application of antiviral agents for influenza and rhinovirus infections. He has published over 300 peer-reviewed articles, chapters, and reviews, and co-edited the textbook Clinical Virology, the third edition of which was published in 2009 by the American Society for Microbiology. Dr Hayden chaired the writing committees for two WHO clinical consultations on avian H5N1 and one on pandemic H1N1 influenza and is a member of IDSA’s Pandemic Influenza Task Force. He is respiratory virus section editor for Antiviral Therapy and a Fellow of the Infectious Diseases Society of America, American Academy of Microbiology, American College of Physicians, American Society for Clinical Investigation, and Association of American Physicians.



<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.